apoE Antibodies

Santa Cruz Biotechnology offers a broad range of apoE monoclonal antibodies for investigating apolipoprotein E (apoE) in various biological processes. apoE Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein E is essential for lipid metabolism and facilitates the transport and clearance of lipoproteins in the bloodstream. Research has shown that apoE plays a significant role in neurodegenerative diseases, particularly Alzheimer's disease, where specific isoforms are associated with varying risks of disease development. Understanding apoE function and mechanisms continues to be a focus in neuroscience research. Scientists worldwide use apoE monoclonal antibodies to advance their studies in lipid metabolism and neurodegeneration. Current investigations of apoE are revealing new insights into potential therapeutic approaches for various diseases. The development of targeted treatments for conditions involving apoE dysfunction remains an active area of research. Santa Cruz Biotechnology monoclonal antibodies for apoE research support scientists in making meaningful contributions to understanding disease mechanisms and developing new therapeutic strategies.